BRCA1 regulates PIG3-mediated apoptosis in a p53-dependent manner
Metrics: PDF 1417 views | HTML 1539 views | ?
Wenwen Zhang1,*, Jiayan Luo1,*, Fengxia Chen1,*, Fang Yang1, Wei Song2, Aiyu Zhu2, Xiaoxiang Guan1,2
1Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China
2Department of Medical Oncology, Jinling Hospital, School of Medicine, Southern Medical University, Guangzhou 510282, China
*These authors have contributed equally to this work
Xiaoxiang Guan, e-mail: email@example.com
Keywords: PIG3, BRCA1, p53, prohibitin, breast cancer
Received: December 28, 2014 Accepted: January 31, 2015 Published: February 18, 2015
BRCA1 plays a key role in the regulation of p53-dependent target gene transcription activation. Meanwhile, the p53 inducible gene 3 (PIG3) is a downstream target of p53 and is involved in p53-initiated apoptosis. However, little is known about whether BRCA1 can regulate PIG3-mediated apoptosis. Using a tissue microarray containing 149 breast cancer patient samples, we found that BRCA1 and PIG3 expression status were significantly positively correlated (r = 0.678, P < 0.001) and identified a significant positive correlation between high expression of BRCA1 and/or PIG3 and overall survival (OS). Moreover, we reveal that overexpression of BRCA1 significantly increased expression of PIG3 in cells with intact p53, whereas no increase in PIG3 was observed in p53-null MDA-MB-157 cells and p53-depleted HCT116p53−/− cells. Meanwhile, ectopic expression of BRCA1 could not lead to an increase expression level of prohibitin (PHB), which we have previously identified to induce PIG3-mediated apoptosis. Finally, ChIP analysis revealed that PHB can bind to the PIG3 promoter and activate PIG3 transcription independent of p53, although p53 presence did enhance this process. Taken together, our findings suggest that BRCA1 regulates PIG3-mediated apoptosis in a p53-dependent manner, and that PIG3 expression is associated with a better OS in breast cancer patients.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.